1. Home
  2. ASYS vs ZNTL Comparison

ASYS vs ZNTL Comparison

Compare ASYS & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

N/A

Current Price

$16.47

Market Cap

312.2M

Sector

Technology

ML Signal

N/A

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

N/A

Current Price

$2.63

Market Cap

289.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASYS
ZNTL
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.2M
289.0M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ASYS
ZNTL
Price
$16.47
$2.63
Analyst Decision
Buy
Buy
Analyst Count
2
11
Target Price
★ $22.50
$7.33
AVG Volume (30 Days)
213.7K
★ 1.3M
Earning Date
08-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.03
EPS
★ 0.19
N/A
Revenue
★ $79,364,000.00
N/A
Revenue This Year
$8.11
N/A
Revenue Next Year
$39.86
N/A
P/E Ratio
$85.32
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.75
$1.21
52 Week High
$25.71
$6.95

Technical Indicators

Market Signals
Indicator
ASYS
ZNTL
Relative Strength Index (RSI) 53.16 36.54
Support Level $15.89 $2.09
Resistance Level $17.57 $2.69
Average True Range (ATR) 0.63 0.17
MACD 0.09 0.02
Stochastic Oscillator 49.00 30.67

Price Performance

Historical Comparison
ASYS
ZNTL

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: